Ontology highlight
ABSTRACT:
ORGANISM(S): Homo sapiens
SUBMITTER: Charles Warden
PROVIDER: E-GEOD-55004 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
Chen Mei-Chuan MC Zhou Bingsen B Zhang Keqiang K Yuan Yate-Ching YC Un Frank F Hu Shuya S Chou Chih-Ming CM Chen Chun-Han CH Wu Jun J Wang Yan Y Liu Xiyong X Smith D Lynne DL Li Hongzhi H Liu Zheng Z Warden Charles D CD Su Leila L Malkas Linda H LH Chung Young Min YM Hu Mickey C-T MC Yen Yun Y
Molecular pharmacology 20150326 6
COH29 [N-(4-(3,4-dihydroxyphenyl)-5-phenylthiazol-2-yl)-3,4-dihydroxybenzamide], a novel antimetabolite drug developed at City of Hope Cancer Center, has anticancer activity that stems primarily from the inhibition of human ribonucleotide reductase (RNR). This key enzyme in deoxyribonucleotide biosynthesis is the target of established clinical agents such as hydroxyurea and gemcitabine because of its critical role in DNA replication and repair. Herein we report that BRCA-1-defective human breast ...[more]